Navigation Links
Quest Diagnostics Declares Quarterly Cash Dividend
Date:12/9/2009

MADISON, N.J., Dec. 9 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, payable on January 22, 2010, to shareholders of record of Quest Diagnostics common stock on January 7, 2010.

About Quest Diagnostics

Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at: www.questdiagnostics.com.


Quest Diagnostics Contacts:
Kathleen Valentine (Investors): 973-520-2900
Wendy Bost (Media): 973-520-2800

SOURCE Quest Diagnostics Incorporated


'/>"/>
SOURCE Quest Diagnostics Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. HemaQuest Pharmaceuticals Presents Promising Results in Sickle Cell Disease and Beta Thalassemia
2. MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug"
3. Hungarian Cancer Formula Producer Questions U.S. Introduction of AveUltra
4. SciScout LLC Launches SciAnswers.com, a Science-Based Questions and Answers (Q&A) Site with a Social Networking Perspective.
5. GenomeQuest Places ChIP-Seq Workflow Solution On SDM “Cloud”
6. Quest PharmaTech Acquires Late-Stage Immunotherapeutic Antibody Pipeline
7. GeoVax Labs Requests pre-IND Meeting With FDA
8. Stemedica Requests Pre-IND Meeting With FDA
9. Five Questions About Protopic (tacrolimus) Ointment
10. FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics Focus Diagnostics Business
11. How much is life worth? The $440 billion question
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... Biopsies from ... heterogeneous samples with limited tumor content in a large background of normal or ... as the need for reliable detection of low abundance somatic mutations, particularly in ...
(Date:3/27/2017)... NC (PRWEB) , ... March 27, 2017 , ... ... Clinical Trial Collaborations (CTC) conference presented by The Conference Forum in Boston on ... way they collaborate to drive improved clinical trial outcomes and bring them closer to ...
(Date:3/24/2017)... MARIETTA, Ga. , March 24, 2017 ... and biopharmaceutical company utilizing human placental tissue allografts and ... therapies for multiple sectors of healthcare, announced today  that ... New York , NY.  Parker H. ... , Chief Financial Officer, Christopher M. Cashman , ...
(Date:3/24/2017)... Calif. , March 24, 2017   Sienna ... and aesthetics company, today announced that Richard Peterson ... effective March 24.   Peterson, who brings more ... John Smither , who is retiring at the ... in an advisory capacity. Peterson joins Sienna from Novan, ...
Breaking Biology Technology:
(Date:3/1/2017)... -- Aware, Inc. (NASDAQ: AWRE), a leading supplier of biometrics ... has resigned, effective March 3, 2017, as co-Chief ... Treasurer of Aware citing a desire to retire.  Mr. ... the Board of Directors of Aware. ... co-President, General Counsel has been named Chief Executive Officer, ...
(Date:2/28/2017)... 27. Februar 2017  EyeLock LLC, ein marktführendes Unternehmen ... erstklassige biometrische Lösung zur Iris-Erkennung auf der ... LTE auf dem Mobile World Congress 2017 ... in Halle 3, Stand 3E10, vorstellen. ... Qualcomm Haven™ – eine Kombination aus Hardware, ...
(Date:2/24/2017)... -- EyeLock LLC, a leader of iris-based identity authentication ... solution on the latest Qualcomm® Snapdragon™ 835 mobile ... Congress 2017 (February 27 – March 2, ... Stand 3E10. The Snapdragon 835 ... combination of hardware, software and biometrics technologies ...
Breaking Biology News(10 mins):